Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1996 Aug;61(2):127–130. doi: 10.1136/jnnp.61.2.127

The basis for behavioural disturbances in dementia.

M M Esiri
PMCID: PMC1073982  PMID: 8708676

Full text

PDF
127

Images in this article

128Image
on p.128
130Image
on p.130

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adolfsson R., Gottfries C. G., Roos B. E., Winblad B. Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry. 1979 Sep;135:216–223. doi: 10.1192/bjp.135.3.216. [DOI] [PubMed] [Google Scholar]
  2. Aletrino M. A., Vogels O. J., Van Domburg P. H., Ten Donkelaar H. J. Cell loss in the nucleus raphes dorsalis in Alzheimer's disease. Neurobiol Aging. 1992 Jul-Aug;13(4):461–468. doi: 10.1016/0197-4580(92)90073-7. [DOI] [PubMed] [Google Scholar]
  3. Alexopoulos G. S., Abrams R. C., Young R. C., Shamoian C. A. Cornell Scale for Depression in Dementia. Biol Psychiatry. 1988 Feb 1;23(3):271–284. doi: 10.1016/0006-3223(88)90038-8. [DOI] [PubMed] [Google Scholar]
  4. Arai H., Kosaka K., Iizuka R. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia. J Neurochem. 1984 Aug;43(2):388–393. doi: 10.1111/j.1471-4159.1984.tb00913.x. [DOI] [PubMed] [Google Scholar]
  5. Bondareff W., Mountjoy C. Q., Roth M. Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology. 1982 Feb;32(2):164–168. doi: 10.1212/wnl.32.2.164. [DOI] [PubMed] [Google Scholar]
  6. Bowen D. M., Smith C. B., White P., Davison A. N. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain. 1976 Sep;99(3):459–496. doi: 10.1093/brain/99.3.459. [DOI] [PubMed] [Google Scholar]
  7. Burnet P. W., Eastwood S. L., Lacey K., Harrison P. J. The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain. Brain Res. 1995 Apr 3;676(1):157–168. doi: 10.1016/0006-8993(95)00104-x. [DOI] [PubMed] [Google Scholar]
  8. Carlsson A. Brain neurotransmitters in aging and dementia: similar changes across diagnostic dementia groups. Gerontology. 1987;33(3-4):159–167. doi: 10.1159/000212870. [DOI] [PubMed] [Google Scholar]
  9. Chan-Palay V., Asan E. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. J Comp Neurol. 1989 Sep 15;287(3):373–392. doi: 10.1002/cne.902870308. [DOI] [PubMed] [Google Scholar]
  10. Chen C. P., Alder J. T., Bowen D. M., Esiri M. M., McDonald B., Hope T., Jobst K. A., Francis P. T. Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication. J Neurochem. 1996 Apr;66(4):1592–1598. doi: 10.1046/j.1471-4159.1996.66041592.x. [DOI] [PubMed] [Google Scholar]
  11. Chui H. C., Mortimer J. A., Slager U., Zarow C., Bondareff W., Webster D. D. Pathologic correlates of dementia in Parkinson's disease. Arch Neurol. 1986 Oct;43(10):991–995. doi: 10.1001/archneur.1986.00520100013007. [DOI] [PubMed] [Google Scholar]
  12. Coyle J. T., Price D. L., DeLong M. R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 1983 Mar 11;219(4589):1184–1190. doi: 10.1126/science.6338589. [DOI] [PubMed] [Google Scholar]
  13. D'Amato R. J., Zweig R. M., Whitehouse P. J., Wenk G. L., Singer H. S., Mayeux R., Price D. L., Snyder S. H. Aminergic systems in Alzheimer's disease and Parkinson's disease. Ann Neurol. 1987 Aug;22(2):229–236. doi: 10.1002/ana.410220207. [DOI] [PubMed] [Google Scholar]
  14. Davies P., Maloney A. J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 1976 Dec 25;2(8000):1403–1403. doi: 10.1016/s0140-6736(76)91936-x. [DOI] [PubMed] [Google Scholar]
  15. Foote S. L., Bloom F. E., Aston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev. 1983 Jul;63(3):844–914. doi: 10.1152/physrev.1983.63.3.844. [DOI] [PubMed] [Google Scholar]
  16. Francis P. T., Palmer A. M., Sims N. R., Bowen D. M., Davison A. N., Esiri M. M., Neary D., Snowden J. S., Wilcock G. K. Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. N Engl J Med. 1985 Jul 4;313(1):7–11. doi: 10.1056/NEJM198507043130102. [DOI] [PubMed] [Google Scholar]
  17. Förstl H., Burns A., Luthert P., Cairns N., Lantos P., Levy R. Clinical and neuropathological correlates of depression in Alzheimer's disease. Psychol Med. 1992 Nov;22(4):877–884. doi: 10.1017/s0033291700038459. [DOI] [PubMed] [Google Scholar]
  18. Gibson C. J., Logue M., Growdon J. H. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease. Arch Neurol. 1985 May;42(5):489–492. doi: 10.1001/archneur.1985.04060050091016. [DOI] [PubMed] [Google Scholar]
  19. Glennon R. A. Serotonin receptors: clinical implications. Neurosci Biobehav Rev. 1990 Spring;14(1):35–47. doi: 10.1016/s0149-7634(05)80158-7. [DOI] [PubMed] [Google Scholar]
  20. Halliday G. M., McCann H. L., Pamphlett R., Brooks W. S., Creasey H., McCusker E., Cotton R. G., Broe G. A., Harper C. G. Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation. Acta Neuropathol. 1992;84(6):638–650. doi: 10.1007/BF00227741. [DOI] [PubMed] [Google Scholar]
  21. Hope T., Fairburn C. G. The Present Behavioural Examination (PBE): the development of an interview to measure current behavioural abnormalities. Psychol Med. 1992 Feb;22(1):223–230. doi: 10.1017/s0033291700032888. [DOI] [PubMed] [Google Scholar]
  22. Iversen L. L., Rossor M. N., Reynolds G. P., Hills R., Roth M., Mountjoy C. Q., Foote S. L., Morrison J. H., Bloom F. E. Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type. Neurosci Lett. 1983 Aug 19;39(1):95–100. doi: 10.1016/0304-3940(83)90171-4. [DOI] [PubMed] [Google Scholar]
  23. Kalaria R. N., Andorn A. C., Tabaton M., Whitehouse P. J., Harik S. I., Unnerstall J. R. Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus. J Neurochem. 1989 Dec;53(6):1772–1781. doi: 10.1111/j.1471-4159.1989.tb09242.x. [DOI] [PubMed] [Google Scholar]
  24. Kral V. A., Emery O. B. Long-term follow-up of depressive pseudodementia of the aged. Can J Psychiatry. 1989 Jun;34(5):445–446. doi: 10.1177/070674378903400515. [DOI] [PubMed] [Google Scholar]
  25. Kral V. A. The relationship between senile dementia (Alzheimer type) and depression. Can J Psychiatry. 1983 Jun;28(4):304–306. doi: 10.1177/070674378302800414. [DOI] [PubMed] [Google Scholar]
  26. Mann D. M. The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system. Mech Ageing Dev. 1983 Sep;23(1):73–94. doi: 10.1016/0047-6374(83)90100-8. [DOI] [PubMed] [Google Scholar]
  27. Marcyniuk B., Mann D. M., Yates P. O. The topography of cell loss from locus caeruleus in Alzheimer's disease. J Neurol Sci. 1986 Dec;76(2-3):335–345. doi: 10.1016/0022-510x(86)90179-6. [DOI] [PubMed] [Google Scholar]
  28. McKeith I., Fairbairn A., Perry R., Thompson P., Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ. 1992 Sep 19;305(6855):673–678. doi: 10.1136/bmj.305.6855.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Palmer A. M., Francis P. T., Benton J. S., Sims N. R., Mann D. M., Neary D., Snowden J. S., Bowen D. M. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J Neurochem. 1987 Jan;48(1):8–15. doi: 10.1111/j.1471-4159.1987.tb13120.x. [DOI] [PubMed] [Google Scholar]
  30. Palmer A. M., Francis P. T., Bowen D. M., Benton J. S., Neary D., Mann D. M., Snowden J. S. Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease. Brain Res. 1987 Jun 30;414(2):365–375. doi: 10.1016/0006-8993(87)90018-7. [DOI] [PubMed] [Google Scholar]
  31. Palmer A. M., Sims N. R., Bowen D. M., Neary D., Palo J., Wikstrom J., Davison A. N. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. J Neurol Neurosurg Psychiatry. 1984 May;47(5):481–484. doi: 10.1136/jnnp.47.5.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Palmer A. M., Wilcock G. K., Esiri M. M., Francis P. T., Bowen D. M. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease. Brain Res. 1987 Jan 20;401(2):231–238. doi: 10.1016/0006-8993(87)91408-9. [DOI] [PubMed] [Google Scholar]
  33. Patterson M. B., Bolger J. P. Assessment of behavioral symptoms in Alzheimer disease. Alzheimer Dis Assoc Disord. 1994;8 (Suppl 3):4–20. [PubMed] [Google Scholar]
  34. Perry E. K., Irving D., Kerwin J. M., McKeith I. G., Thompson P., Collerton D., Fairbairn A. F., Ince P. G., Morris C. M., Cheng A. V. Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord. 1993 Summer;7(2):69–79. doi: 10.1097/00002093-199307020-00002. [DOI] [PubMed] [Google Scholar]
  35. Perry E. K., Marshall E., Thompson P., McKeith I. G., Collerton D., Fairbairn A. F., Ferrier I. N., Irving D., Perry R. H. Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features. J Neural Transm Park Dis Dement Sect. 1993;6(3):167–177. doi: 10.1007/BF02260919. [DOI] [PubMed] [Google Scholar]
  36. Perry E. K., Tomlinson B. E., Blessed G., Bergmann K., Gibson P. H., Perry R. H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J. 1978 Nov 25;2(6150):1457–1459. doi: 10.1136/bmj.2.6150.1457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Raskind M. A., Peskind E. R., Halter J. B., Jimerson D. C. Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease. Arch Gen Psychiatry. 1984 Apr;41(4):343–346. doi: 10.1001/archpsyc.1984.01790150033006. [DOI] [PubMed] [Google Scholar]
  38. Raskind M. A., Peskind E. R. Neurobiologic bases of noncognitive behavioral problems in Alzheimer disease. Alzheimer Dis Assoc Disord. 1994;8 (Suppl 3):54–60. [PubMed] [Google Scholar]
  39. Reding M., Haycox J., Blass J. Depression in patients referred to a dementia clinic. A three-year prospective study. Arch Neurol. 1985 Sep;42(9):894–896. doi: 10.1001/archneur.1985.04060080080019. [DOI] [PubMed] [Google Scholar]
  40. Weiler P. G., Mungas D., Bernick C. Propranolol for the control of disruptive behavior in senile dementia. J Geriatr Psychiatry Neurol. 1988 Oct-Dec;1(4):226–230. doi: 10.1177/089198878800100408. [DOI] [PubMed] [Google Scholar]
  41. Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., Coyle J. T., Delon M. R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 1982 Mar 5;215(4537):1237–1239. doi: 10.1126/science.7058341. [DOI] [PubMed] [Google Scholar]
  42. Wilcock G. K., Esiri M. M., Bowen D. M., Smith C. C. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci. 1982 Dec;57(2-3):407–417. doi: 10.1016/0022-510x(82)90045-4. [DOI] [PubMed] [Google Scholar]
  43. Wisniewski H. M., Constantinidis J., Wegiel J., Bobinski M., Tarnawski M. Neurofibrillary pathology in brains of elderly schizophrenics treated with neuroleptics. Alzheimer Dis Assoc Disord. 1994 Winter;8(4):211–227. doi: 10.1097/00002093-199408040-00001. [DOI] [PubMed] [Google Scholar]
  44. Yamamoto T., Hirano A. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons. Ann Neurol. 1985 Jun;17(6):573–577. doi: 10.1002/ana.410170608. [DOI] [PubMed] [Google Scholar]
  45. Yudofsky S., Williams D., Gorman J. Propranolol in the treatment of rage and violent behavior in patients with chronic brain syndromes. Am J Psychiatry. 1981 Feb;138(2):218–220. doi: 10.1176/ajp.138.2.218. [DOI] [PubMed] [Google Scholar]
  46. Zubenko G. S., Moossy J. Major depression in primary dementia. Clinical and neuropathologic correlates. Arch Neurol. 1988 Nov;45(11):1182–1186. doi: 10.1001/archneur.1988.00520350020008. [DOI] [PubMed] [Google Scholar]
  47. Zweig R. M., Cardillo J. E., Cohen M., Giere S., Hedreen J. C. The locus ceruleus and dementia in Parkinson's disease. Neurology. 1993 May;43(5):986–991. doi: 10.1212/wnl.43.5.986. [DOI] [PubMed] [Google Scholar]
  48. Zweig R. M., Ross C. A., Hedreen J. C., Steele C., Cardillo J. E., Whitehouse P. J., Folstein M. F., Price D. L. The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol. 1988 Aug;24(2):233–242. doi: 10.1002/ana.410240210. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES